Company description

IBT Bioservices is a biotechnology-focused contract research organisation headquartered in Rockville, Maryland, providing integrated research and development support to pharmaceutical, biotechnology and government clients. Founded in 2005, the company operates as a full-service CRO delivering both in vitro and in vivo services alongside reagent production and assay development.

The company specialises in supporting the development of vaccines and therapeutics, with particular expertise in infectious diseases and immunology. Its work spans early-stage discovery through to clinical development, enabling clients to progress novel therapies from preclinical evaluation to clinical application.

IBT Bioservices positions itself as a “one-stop shop” CRO, combining scientific expertise, laboratory capabilities and tailored project support to accelerate drug development. Its teams of scientists and researchers collaborate closely with clients, offering customised solutions designed to simplify complex development pathways and improve efficiency.

With capabilities including biosafety level-2 laboratories and access to higher containment through partnerships, IBT supports advanced infectious disease research and translational development. The company works with organisations ranging from biotech start-ups to large pharmaceutical firms, as well as academic and government institutions.

Key products and services

In vitro research services

• Cell-based assays, immunoassays and multiplex assays (e.g. ELISA, Luminex)

• Antiviral and antibacterial testing

• Custom assay development and reagent production

In vivo preclinical services

• Animal disease models for viral and bacterial infections

• Immunogenicity, pharmacokinetics (PK) and biodistribution studies

• Toxicology and efficacy studies for therapeutics and vaccines

Assay and model development

• Custom disease model development

• Functional assay design and optimisation

• IND-enabling studies and early-stage screening

Reagents and research products

• Recombinant proteins, antibodies and ELISA kits

• Virus-like particles and pseudoviruses

• Reporter cell lines and specialised research reagents

Integrated CRO support

• End-to-end support from protocol design to final data

• Programme management and sample handling

• Tailored project support for biotech, pharma and government clients

By combining specialised infectious disease expertise with integrated laboratory, preclinical and clinical capabilities, IBT Bioservices positions itself as a strategic partner for organisations developing next-generation therapeutics and vaccines. Its “one-stop shop” CRO model enables clients to streamline development, generate robust scientific data and accelerate the translation of innovative biomedical solutions from research to patient impact.